Cite
HARVARD Citation
Egeberg, A. et al. (2017). Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate‐to‐severe plaque psoriasis – nationwide results from the DERMBIO registry. Journal of the European Academy of Dermatology and Venereology. pp. 1183-1187. [Online].